Man holding health IT icon
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Healthcare technology company Alcidion Group Ltd (ASX:ALC) has signed a contract with Peninsula Health allowing the latter to use its Miya Precision platform which facilitates various aspects of patient data management.

The contract – which will last for 5 years and is valued at $3.7 million – will enable the various health service entities grouped under Peninsula to access leading technology supporting results management, patient records access, and patient flow management.

As such, it is expected to lessen the administrative burden on frontline hospital staff.

Alcidion CEO and managing director Kate Quirke said the technology would support patients and families Peninsula’s hospitals and clinics across the Frankston and Mornington Peninsula region.

“This deal represents a meaningful step forward for patients and families seeking healthcare in southern Victoria,” she said.

“As part of the Contract, Alcidion will implement an electronic patient flow management solution, which includes a real time user interface showcasing demand, capacity, predicted availability, and tracking for all admitted and emergency patients within all Peninsula Health sites, integrated with the existing electronic medical record.

“We are leading a new frontier of innovative and measured healthcare with the Peninsula Health team, which addresses some of the most pressing healthcare challenges of our time – availability and accessibility.”

Alcidion shares moved up on the news, and at 16:35 AEDT, they were trading at 6.6 cents – a rise of 8.2% since the market opened.

Join the discussion: See what HotCopper users are saying about Alcidion and be part of the conversations that move the markets.


alc by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX 200 rallies as risk appetite returns, but business confidence weakens

The Australian sharemarket finished firmly higher today with the S&P/ASX 200 adding 106.50 points, or 1.18%, to close at 9,136.20.

EVE Health Group signs Australian compounding agreement for rapidly rising Men’s Health issue

EVE Health Group has signed an agreement with Optimal Pharmacy Plus Stafford aimed at the Australian…

Nanoveu’s EMASS signs DigiKey as Global Distributor for ECS-DoT-22

Nanoveu's wholly-owned subsidiary EMASS has signed DigiKey as its global distributor for ECS-DoT-22 system.
The Market Online Video

Wealth Within: Wall Street Tech Sinks While ASX Tech Soars

Wall Street’s technology stocks have been hammered, with the Nasdaq plunging 5.5 per cent in a single session and Nvidia falling more tha…